A booster of Pfizer-BioNTech’s COVID-19 vaccine has proved highly effective in warding off disease from the dominant delta strain of the coronavirus, according to preliminary results of a late-stage trial.
The booster dose was 95.6% at preventing disease, compared to those who didn’t receive an extra shot in ...
from The Washington Times stories: Health https://ift.tt/3vCUQyj